Outcomes of emergency department patients presenting with adverse drug events.

STUDY OBJECTIVE Our objectives are to describe the outcomes of patients presenting to the emergency department (ED) because of an adverse drug event and to compare them with outcomes of patients presenting for other reasons. METHODS This prospective observational study was conducted at Vancouver General Hospital, a 955-bed tertiary care hospital. We prospectively enrolled adults presenting to the ED between March and June 2006, using a systematic sampling algorithm. Pharmacists and physicians independently evaluated patients for adverse drug events. An independent committee reviewed and adjudicated cases in which assessments were discordant or uncertain. Data from the index visit were linked to vital statistics, administrative health services utilization, and cost of care data. RESULTS Of 1,000 patients, 122 (12.2%; 95% confidence interval [CI] 10.3% to 14.4%) presented to the ED because of an adverse drug event. Of these, 48 presented because of an adverse drug reaction (one type of adverse drug event defined as an unintended response that occurred despite use of an appropriate drug dosage). We found no difference in mortality among patients presenting with and without adverse drug reactions (14.6% versus 5.9%; hazard ratio 1.57; 95% CI 0.70 to 3.52). After adjustment, patients with adverse drug events had a higher risk of spending additional days in the hospital per month (6.3% versus 3.4%; odds ratio 1.52; 95% CI 1.43 to 1.62) and higher rate of outpatient health care encounters (1.73 versus 1.22; rate ratio 1.20; 95% CI 1.03 to 1.40). The adjusted median monthly cost of care was 1.90 times higher (Can $325 versus $96; 95% CI 1.18 to 3.08). CONCLUSION ED patients presenting with an adverse drug event incurred greater health services utilization and costs during a 6-month follow-up period compared with patients presenting for other reasons.

[1]  N. Laird,et al.  Incidence of Adverse Drug Events and Potential Adverse Drug Events: Implications for Prevention , 1995 .

[2]  Kay Brune,et al.  Incidence and Costs of Adverse Drug Reactions During Hospitalisation , 2000, Drug safety.

[3]  Charles E. McCulloch,et al.  Regression Methods in Biostatistics: Linear, Logistic, Survival, and Repeated Measures Models , 2005 .

[4]  J. Brubacher,et al.  Do emergency physicians attribute drug-related emergency department visits to medication-related problems? , 2010, Annals of emergency medicine.

[5]  P. Corey,et al.  Incidence of Adverse Drug Reactions in Hospitalized Patients , 2012 .

[6]  D. Hosmer,et al.  Applied Logistic Regression , 1991 .

[7]  Automating Patient Acuity in Critical Care Units from Nursing Documentation , 1984 .

[8]  Bengt Jönsson,et al.  Pharmacoeconomics of adverse drug reactions , 2004, Fundamental & clinical pharmacology.

[9]  D. Miranda.  The therapeutic intervention scoring system: one single tool for the evaluation of workload, the work process and management? , 1997, Intensive Care Medicine.

[10]  D. Bates,et al.  Incidence and preventability of adverse drug events among older persons in the ambulatory setting. , 2003, JAMA.

[11]  C. Hepler,et al.  Opportunities and responsibilities in pharmaceutical care. , 1990, American journal of hospital pharmacy.

[12]  R. Alaghehbandan,et al.  Adverse Drug Events in Adult Patients Leading to Emergency Department Visits , 2010, The Annals of pharmacotherapy.

[13]  D. Pollock,et al.  National surveillance of emergency department visits for outpatient adverse drug events. , 2006, JAMA.

[14]  M. Drummond,et al.  Health Care Technology: Effectiveness, Efficiency and Public Policy@@@Methods for the Economic Evaluation of Health Care Programmes , 1988 .

[15]  Alan J. Forster,et al.  Ottawa Hospital Patient Safety Study: incidence and timing of adverse events in patients admitted to a Canadian teaching hospital , 2004, Canadian Medical Association Journal.

[16]  D. Greenblatt,et al.  A method for estimating the probability of adverse drug reactions , 1981, Clinical pharmacology and therapeutics.

[17]  A. Melck,et al.  The Cost-Effectiveness of Three Strategies for the Surgical Treatment of Symptomatic Primary Hyperparathyroidism , 2008, Annals of Surgical Oncology.

[18]  M Maclure,et al.  Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. , 2001, American journal of epidemiology.

[19]  S. Sheps,et al.  The Canadian Adverse Events Study: the incidence of adverse events among hospital patients in Canada , 2004, Canadian Medical Association Journal.

[20]  T. Brennan,et al.  The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. , 1991, The New England journal of medicine.

[21]  D. Bates,et al.  The Costs of Adverse Drug Events in Hospitalized Patients , 1997 .

[22]  Hude Quan,et al.  Validity of Information on Comorbidity Derived From ICD-9-CCM Administrative Data , 2002, Medical care.

[23]  M. Afilalo,et al.  Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. , 2001, Annals of emergency medicine.

[24]  K. Wilbur,et al.  Drug‐Related Hospitalizations in a Tertiary Care Internal Medicine Service of a Canadian Hospital: A Prospective Study , 2006, Pharmacotherapy.

[25]  Tracey A. Young,et al.  Estimating mean total costs in the presence of censoring , 2012, PharmacoEconomics.

[26]  Matthew M. Burton,et al.  The cost of adverse drug events in ambulatory care. , 2007, AMIA ... Annual Symposium proceedings. AMIA Symposium.

[27]  M. Pirmohamed,et al.  Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients , 2004, BMJ : British Medical Journal.

[28]  C. Naranjo,et al.  Comparison of the Bayesian approach and a simple algorithm for assessment of adverse drug events * , 1995, Clinical pharmacology and therapeutics.

[29]  A. Anis,et al.  A cost-effectiveness analysis of propofol versus midazolam for procedural sedation in the emergency department. , 2008, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[30]  Grazyna Adamiak,et al.  Methods for the economic evaluation of health care programmes, 3rd ed , 2006 .

[31]  S. Schroeder,et al.  How Many Hours Is Enough? An Old Profession Meets a New Generation , 2004, Annals of Internal Medicine.

[32]  J. Brubacher,et al.  Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study , 2008, Canadian Medical Association Journal.

[33]  R M Poses,et al.  Controlling for confounding by indication for treatment. Are administrative data equivalent to clinical data? , 1995, Medical care.

[34]  David W Bates,et al.  The Costs Associated With Adverse Drug Events Among Older Adults in the Ambulatory Setting , 2005, Medical care.

[35]  D. Classen,et al.  Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. , 1997, JAMA.

[36]  P. Zed,et al.  Drug-Related Visits to the Emergency Department , 2005 .

[37]  D. Cox,et al.  Analysis of Survival Data. , 1985 .

[38]  P. Barach,et al.  Clarifying Adverse Drug Events: A Clinician's Guide to Terminology, Documentation, and Reporting , 2004, Annals of Internal Medicine.

[39]  A. Egberts,et al.  Adverse drug events in hospitalized patients A comparison of doctors, nurses and patients as sources of reports , 1999, European Journal of Clinical Pharmacology.

[40]  C. Raehl,et al.  Adverse Drug Reactions in United States Hospitals , 2006, Pharmacotherapy.

[41]  J. Chan,et al.  Effectiveness of telephone counselling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomised controlled trial , 2006, BMJ : British Medical Journal.

[42]  J. A. Johnson,et al.  Drug-Related Morbidity and Mortality: A Cost-of-Illness Model , 1995 .

[43]  M. Afilalo,et al.  Emergency physician recognition of adverse drug-related events in elder patients presenting to an emergency department. , 2005, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[44]  I. Edwards,et al.  Adverse drug reactions: definitions, diagnosis, and management , 2000, The Lancet.